Physician profile
David Brunk
NPI 1982790150
$18,337.57
in general payments reported to CMS, 2019-2025
33 companies · $5,492 in 2025
The $5,492 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $485 · 2022: $1,512 · 2023: $5,098 · 2024: $5,750 · 2025: $5,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,807 · Travel and Lodging: $4,533 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,807.19 |
| Travel and Lodging | $4,533.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,650.12 | 2021-2025 | Watchman Access System, Watchman, Farapulse |
| Atricure, INC. | $2,217.54 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,647.99 | 2023 | Micra |
| Novartis Pharmaceuticals Corporation | $961.95 | 2021-2025 | |
| Pfizer INC. | $812.03 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $733.69 | 2021-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $517.74 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $486.83 | 2021-2024 | Xarelto |
| Amgen INC. | $447.18 | 2022-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $389.58 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Philips North America LLC | $304.82 | 2022-2025 | (Ck4) Mcot, Extended Holter, (Ck7) Extended Holter |
| Impulse Dynamics (USA) INC. | $295.19 | 2022-2025 | Optimizer, Optimizer |
| Sanofi-Aventis U.S. LLC | $270.28 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.58 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $176.77 | 2021-2024 | Verquvo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $176.10 | 2022-2025 | Amvuttra |
| Biosense Webster, INC. | $146.28 | 2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $119.85 | 2023-2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $106.64 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $103.38 | 2022-2025 | Farxiga |
| Baxter Healthcare | $64.41 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $54.28 | 2025 | Inspire |
| Bardy Diagnostics, INC. | $54.01 | 2022 | |
| Abbott Laboratories | $48.61 | 2022-2023 | Mitraclip |
| Kiniksa Pharmaceuticals, LTD. | $47.80 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $42.43 | 2024 | Arcalyst |
| Heartflow, INC. | $41.40 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $37.52 | 2022 | |
| Esperion Therapeutics, INC. | $37.04 | 2021-2022 | |
| Daiichi Sankyo INC. | $30.05 | 2023-2024 | Injectafer |
| Abiomed | $24.54 | 2024 | Impella |
| Scpharmaceuticals INC. | $21.89 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.